SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

NEUROMODULATION is a premier academic journal dedicated to advancing the fields of anesthesiology, pain medicine, and neurology. Published by Elsevier, this prestigious journal has consistently maintained a high impact factor, reflecting its relevance and influence in the medical community. With a commendable track record spanning from 1998 to 2024, NEUROMODULATION is classified in the Q1 quartile for both Anesthesiology and Pain Medicine and Medicine (miscellaneous), demonstrating its excellence among top-tier journals. Additionally, it ranks in the Q2 quartile for Neurology and Clinical Neurology, showcasing a broad appeal across multiple disciplines. The journal's substantial Scopus rankings—22nd out of 136 in Anesthesiology and Pain Medicine and 93rd out of 400 in Clinical Neurology—underscore its critical role in disseminating cutting-edge research and clinical findings. NEUROMODULATION endeavors to provide a robust platform for researchers, clinicians, and students to explore innovative therapeutic approaches and the complexities of neural modulation, ultimately contributing to improved patient outcomes and advancing the state of medical science.

Clinical Epileptology, published by Springer Heidelberg, is an emerging open-access journal that aims to advance the understanding of epilepsy through rigorous research and clinical studies. With an ISSN of 2948-104X and E-ISSN of 2948-1058, this journal serves as a vital platform for researchers, clinicians, and students within the fields of Neurology, Pediatrics, and Perinatology. Although still in its formative years, spanning from 2023 to 2024, the journal aspires to fill the knowledge gaps in epilepsy research, thereby improving patient outcomes. Despite its initial Scopus rankings placing it within the 12th and 19th percentiles in respective categories, Clinical Epileptology is poised to make a significant impact by fostering interdisciplinary collaboration and disseminating high-quality findings. With options for open access, this journal ensures that groundbreaking research is readily available to a global audience, encouraging the ongoing dialogue that is crucial to advancing the field. Intended for a diverse readership, including academic researchers, healthcare professionals, and students, Clinical Epileptology is committed to becoming a cornerstone of epilepsy research.

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

ONCOLOGY-NEW YORK is a prominent journal dedicated to the field of oncology, published by UBM MEDICA. Since its inception in 1987, the journal has served as a pivotal platform for disseminating groundbreaking research and advancements in cancer treatment, research, and education. With an ISSN of 0890-9091 and an E-ISSN of 2767-7389, it stands as an accessible resource for professionals, researchers, and students alike. The journal currently holds impressive rankings, categorized within Q3 in Oncology and Q4 in Cancer Research for 2023, reflecting its commitment to high-quality research output and contributions to the field. Despite its challenges in Scopus rankings, positioned at #283/404 in Medicine: Oncology and #188/230 in Biochemistry, Genetics, and Molecular Biology: Cancer Research, ONCOLOGY-NEW YORK continues to primarily focus on innovative cancer therapies and emerging clinical research. The journal's ongoing dedication to enhancing knowledge and understanding in oncology makes it a vital resource for all stakeholders invested in combating cancer.

Welcome to NEUROREHABILITATION, a premier journal dedicated to advancing the field of rehabilitation, specializing in neurology and physical therapy. Published by IOS PRESS, the journal has established itself as a crucial platform for disseminating high-quality, peer-reviewed research since its inception in 1991. Located in the Netherlands, NEUROREHABILITATION has achieved significant recognition within the academic community, reflected in its impressive impact factor and Scopus rankings, including a Q2 categorization in Rehabilitation and Physical Therapy, highlighting its relevance and influence in these essential domains. With a commitment to enhancing clinical practices and outcomes for individuals with neurological conditions, this journal serves as an invaluable resource for researchers, clinicians, and students alike. Although it currently operates under a subscription model, NEUROREHABILITATION continues to contribute meaningfully to the ongoing dialogue in rehabilitation sciences, making it a key player in shaping the future of therapy and patient care.

Epileptic Disorders is a leading journal dedicated to the field of epilepsy research and its clinical implications, published by Wiley. With its ISSN 1294-9361 and E-ISSN 1950-6945, the journal has established a significant presence in the medical and neurological communities, reflecting its commitment to advancing knowledge in the study of epilepsy and related disorders. Covering a broad spectrum of topics, Epileptic Disorders aims to provide a platform for researchers and clinicians to share cutting-edge research findings, clinical insights, and innovative treatments, maintaining a robust presence in Q2 quartiles across multiple categories including Medicine (miscellaneous) and Neurology. The journal, which has been in continuous publication since 1999, also ranks within the 51st and 47th percentiles in the Scopus rankings for Medicine and Neuroscience, respectively, underscoring its relevance and impact in the field. Although not an open-access publication, Epileptic Disorders remains a crucial resource for those seeking to deepen their understanding of epilepsy and improve patient care through research.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.